Clinical Trial Update: Ticagrelor in Remote Ischemic Preconditioning Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ticagrelor in the context of remote ischemic preconditioning for periprocedural myocardial infarction is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprocedural Myocardial Infarction

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Hellenic Society of Interventional Cardiology | Conditions: Periprocedural Myocardial Infarction | Phase 4 | Status: COMPLETED